Jessica Suzanne Zigman, MD
Undefined Physician Type (Specify) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zigman’s office at (650) 934-7520 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A135897 · Current
Licensed to practise in California · since 2015 · expires 2028-12-31 · Medical College of Wisconsin.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$214,392
Medicare paid this office $214,392 for 329 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 61 | $58,208 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 61 | $37,290 | $388 |
| Insertion of lower leg neurostimulator electrode | 40 | $19,284 | $124 |
| Creation of sling around urethra in female to control leakage | 28 | $13,545 | $484 |
| Return visit (30+ min) | 83 | $11,209 | $111 |
See all 12 services
| Botox | 61 | $58,208 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 61 | $37,290 | $388 |
| Insertion of lower leg neurostimulator electrode | 40 | $19,284 | $124 |
| Creation of sling around urethra in female to control leakage | 28 | $13,545 | $484 |
| Return visit (30+ min) | 83 | $11,209 | $111 |
| New patient visit (45+ min) | 79 | $11,205 | $142 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 15 | $10,062 | $671 |
| New patient visit (60+ min) | 49 | $8,280 | $169 |
| Long return visit (40+ min) | 50 | $7,655 | $150 |
| Insertion of temporary bladder tube | 154 | $6,649 | $42 |
| Simple bladder irrigation and/or instillation | 64 | $3,942 | $40 |
| Short return visit (20+ min) | 34 | $3,166 | $77 |
Procedures Medicare counted
| Removal of the uterus | 12 | More than 86% of doctors who do this |
Who their Medicare patients are
329 Original Medicare patients in 2024. Average age 76 · Women 100% · Also on Medicaid 8% · Health risk score 0.85. At or below the middle of the specialty; the typical undefined physician type clinician is at 1.67.
Conditions among them: High blood pressure 60% · Depression 20% · Diabetes 18% · Coronary heart disease 17% · Cancer 16% · Chronic kidney disease 14% · Atrial fibrillation 12% · Heart failure 9% · COPD 8% · Dementia 4% · Stroke 4%.
The office billed $861,572, Medicare allowed $278,903 and paid $214,392; for 12,927 services of 40 kinds; $59,336 of it was for drugs given in the office and $155,056 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 329 | 12,927 | 76 | 0.85 | $861,572 | $214,392 |
| 2023 | 529 | 16,325 | 76 | 0.84 | $1,301,747 | $339,688 |
| 2022 | 441 | 10,353 | 76 | 0.84 | $1,161,676 | $308,914 |
| 2021 | 357 | 6,940 | 76 | 0.87 | $857,080 | $242,121 |
| 2020 | 283 | 4,860 | 76 | 0.89 | $460,492 | $122,714 |
| 2019 | 392 | 8,085 | 75 | 1.05 | $793,824 | $218,666 |
| 2018 | 102 | 1,053 | 75 | 0.95 | $111,134 | $28,996 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Botox | 65 | $70,084 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 65 | $44,859 | $404 |
| Insertion of lower leg neurostimulator electrode | 68 | $40,857 | $117 |
| Return visit (30+ min) | 182 | $27,420 | $114 |
| Creation of sling around urethra in female to control leakage | 50 | $23,759 | $475 |
| New patient visit (60+ min) | 109 | $20,732 | $190 |
| Surgical repair of vaginal defect using an endoscope | 21 | $14,774 | $704 |
| Long return visit (40+ min) | 82 | $13,536 | $156 |
| New patient visit (45+ min) | 88 | $12,809 | $146 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 18 | $12,714 | $706 |
| Insertion of temporary bladder tube | 256 | $11,582 | $44 |
| Short return visit (20+ min) | 99 | $10,138 | $80 |
| Repair of herniated rectum into vaginal wall | 22 | $5,834 | $265 |
| Repair of pelvic ligaments through vagina | 13 | $5,208 | $401 |
| Partial removal of uterus, tubes, and/or ovaries with retention of cervix using an endoscope, 250.0 g or less | 14 | $5,092 | $364 |
| Simple bladder irrigation and/or instillation | 67 | $4,511 | $41 |
| Diagnostic exam of bladder and urethra using an endoscope | 13 | $3,349 | $258 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $584 | $23 |
2022: 16 services
| Insertion of lower leg neurostimulator electrode | 92 | $78,565 | $124 |
| Botox | 42 | $41,202 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 42 | $29,522 | $416 |
| New patient visit (60+ min) | 143 | $27,627 | $193 |
| Return visit (30+ min) | 129 | $20,229 | $119 |
| Long return visit (40+ min) | 87 | $14,968 | $164 |
| Creation of sling around urethra in female to control leakage | 31 | $14,715 | $475 |
| Insertion of temporary bladder tube | 265 | $12,051 | $44 |
| Surgical repair of vaginal defect using an endoscope | 13 | $10,253 | $789 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 14 | $8,468 | $605 |
| New patient visit (45+ min) | 38 | $4,818 | $127 |
| Short return visit (20+ min) | 45 | $3,944 | $82 |
| Repair of herniated rectum into vaginal wall | 14 | $3,787 | $271 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $3,596 | $257 |
| Simple bladder irrigation and/or instillation | 45 | $3,185 | $43 |
| Unclassified drugs | 31 | $186 | None |
2021: 16 services
| Insertion of lower leg neurostimulator electrode | 72 | $66,385 | $134 |
| Botox | 29 | $25,065 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 28 | $18,085 | $402 |
| Return visit (30+ min) | 117 | $17,364 | $121 |
| New patient visit (45+ min) | 87 | $12,808 | $147 |
| New patient visit (60+ min) | 60 | $12,370 | $206 |
| Creation of sling around urethra in female to control leakage | 25 | $11,747 | $470 |
| Long return visit (40+ min) | 54 | $9,201 | $167 |
| Insertion of temporary bladder tube | 197 | $9,177 | $46 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 13 | $6,712 | $516 |
| Diagnostic exam of bladder and urethra using an endoscope | 17 | $4,296 | $253 |
| Short return visit (20+ min) | 32 | $3,344 | $86 |
| Simple bladder irrigation and/or instillation | 32 | $2,853 | $52 |
| New patient visit (30+ min) | 16 | $1,228 | $77 |
| Short return visit | 11 | $623 | $52 |
| Unclassified drugs | 29 | $241 | None |
2020: 12 services
| Insertion of lower leg neurostimulator electrode | 65 | $25,677 | $114 |
| Botox | 24 | $19,238 | None |
| New patient visit (45+ min) | 108 | $15,662 | $145 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 25 | $12,175 | $358 |
| Insertion of temporary bladder tube | 163 | $7,298 | $43 |
| Return visit (30+ min) | 68 | $7,152 | $88 |
| New patient visit (60+ min) | 22 | $4,158 | $189 |
| Long return visit (40+ min) | 14 | $2,259 | $141 |
| New patient visit (30+ min) | 17 | $1,614 | $95 |
| Short return visit (20+ min) | 20 | $1,480 | $64 |
| Simple bladder irrigation and/or instillation | 16 | $803 | $38 |
| Unclassified drugs | 24 | $148 | None |
2019: 16 services
| Insertion of lower leg neurostimulator electrode | 88 | $81,327 | $131 |
| Botox | 31 | $30,578 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 31 | $16,073 | $335 |
| New patient visit (45+ min) | 108 | $15,550 | $144 |
| New patient visit (30+ min) | 133 | $11,398 | $86 |
| Insertion of temporary bladder tube | 260 | $11,135 | $40 |
| Creation of sling around urethra in female to control leakage | 16 | $8,194 | $512 |
| Short return visit (20+ min) | 72 | $5,814 | $68 |
| Return visit (30+ min) | 52 | $5,571 | $99 |
| New patient visit (60+ min) | 21 | $4,011 | $191 |
| Simple bladder irrigation and/or instillation | 32 | $1,909 | $45 |
| Long return visit (40+ min) | 14 | $1,659 | $119 |
| Fitting and insertion of vaginal support device | 25 | $1,464 | $50 |
| Short return visit | 30 | $1,096 | $30 |
| Pessary, reusable, non rubber, any type | 19 | $986 | $45 |
| Unclassified drugs | 23 | $150 | None |
2018: 5 services
| New patient visit (45+ min) | 46 | $6,832 | $149 |
| Insertion of temporary bladder tube | 79 | $3,690 | $46 |
| New patient visit (30+ min) | 23 | $2,337 | $102 |
| Short return visit (20+ min) | 17 | $1,388 | $69 |
| Short return visit | 13 | $597 | $43 |
Drugs they prescribed that Part D paid
$259,543
Pharmacies billed $259,543 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (35 of 680) in 2024. Above the middle of the specialty; the typical undefined physician type clinician is at 0%.
371 generic and 309 brand-name prescriptions · $259,543 in drug cost · 233 antibiotic prescriptions to 126 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 169 | $182,398 | $1,079 |
| Myrbetriq | 36 | $39,264 | $1,091 |
| Estring | 34 | $17,829 | $524 |
| Premarin | 19 | $8,162 | $430 |
| Estradiol | 73 | $7,128 | $98 |
See all 11 drugs
| Gemtesa | 169 | $182,398 | $1,079 |
| Myrbetriq | 36 | $39,264 | $1,091 |
| Estring | 34 | $17,829 | $524 |
| Premarin | 19 | $8,162 | $430 |
| Estradiol | 73 | $7,128 | $98 |
| Nitrofurantoin Mono-Macro | 131 | $890 | $7 |
| Cephalexin | 41 | $389 | $9 |
| Ibuprofen | 31 | $182 | $6 |
| Clobetasol Propionate | 12 | $155 | $13 |
| Sulfamethoxazole-Trimethoprim | 38 | $113 | $3 |
| Oxycodone | 34 | $89 | $3 |
Year by year
| 2024 | 680 | 283 | 5% (35) | 45% | $259,543 |
| 2023 | 1,061 | 378 | 7% (70) | None | $343,484 |
| 2022 | 771 | 295 | 3% (25) | None | $224,500 |
| 2021 | 600 | 243 | 5% (31) | 40% | $138,049 |
| 2020 | 444 | 174 | 5% (22) | None | $104,047 |
| 2019 | 556 | 239 | 2% (13) | 47% | $109,412 |
| 2018 | 122 | 83 | None | 37% | $18,627 |
| 2017 | 173 | 74 | 14% (24) | 18% | $20,083 |
| 2016 | 74 | 34 | None | 28% | $8,501 |
| 2015 | 19 | None | None | None | $2,096 |
| 2014 | 28 | 16 | 57% (16) | None | $4,183 |
| 2013 | 21 | 16 | 57% (12) | None | $12,757 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Gemtesa | 167 | $203,728 | $1,220 |
| Myrbetriq | 74 | $70,303 | $950 |
| Estring | 38 | $21,181 | $557 |
| Premarin | 38 | $17,126 | $451 |
| Estradiol | 123 | $16,733 | $136 |
| Methenamine Hippurate | 15 | $2,692 | $179 |
| Nitrofurantoin Mono-Macro | 228 | $2,458 | $11 |
| Nitrofurantoin | 19 | $1,351 | $71 |
| Metronidazole | 37 | $1,231 | $33 |
| Cephalexin | 58 | $678 | $12 |
| Ibuprofen | 57 | $388 | $7 |
| Oxycodone | 67 | $218 | $3 |
| Clobetasol Propionate | 12 | $179 | $15 |
| Ciprofloxacin | 23 | $111 | $5 |
| Fluconazole | 23 | $81 | $4 |
| Sulfamethoxazole-Trimethoprim | 28 | $76 | $3 |
2022: 16 drugs
| Gemtesa | 85 | $83,335 | $980 |
| Myrbetriq | 77 | $76,017 | $987 |
| Estring | 39 | $20,590 | $528 |
| Premarin | 47 | $20,415 | $434 |
| Estradiol | 98 | $14,051 | $143 |
| Nitrofurantoin Mono-Macro | 178 | $2,382 | $13 |
| Methenamine Hippurate | 12 | $1,611 | $134 |
| Oxybutynin Chloride Er | 11 | $935 | $85 |
| Clobetasol Propionate | 12 | $706 | $59 |
| Cephalexin | 64 | $593 | $9 |
| Metronidazole | 17 | $224 | $13 |
| Ibuprofen | 20 | $212 | $11 |
| Fluconazole | 20 | $113 | $6 |
| Oxycodone | 24 | $88 | $4 |
| Ciprofloxacin | 14 | $66 | $5 |
| Sulfamethoxazole-Trimethoprim | 21 | $59 | $3 |
2021: 14 drugs
| Myrbetriq | 105 | $77,815 | $741 |
| Premarin | 67 | $28,867 | $431 |
| Estring | 24 | $12,040 | $502 |
| Estradiol | 63 | $9,048 | $144 |
| Methenamine Hippurate | 12 | $1,527 | $127 |
| Nitrofurantoin Mono-Macro | 94 | $1,228 | $13 |
| Metronidazole | 26 | $841 | $32 |
| Oxybutynin Chloride Er | 15 | $441 | $29 |
| Clobetasol Propionate | 11 | $303 | $28 |
| Cephalexin | 34 | $220 | $6 |
| Ibuprofen | 26 | $199 | $8 |
| Oxycodone | 30 | $146 | $5 |
| Sulfamethoxazole-Trimethoprim | 35 | $95 | $3 |
| Fluconazole | 14 | $52 | $4 |
2020: 11 drugs
| Myrbetriq | 94 | $53,486 | $569 |
| Premarin | 79 | $32,158 | $407 |
| Estradiol | 20 | $3,621 | $181 |
| Methenamine Hippurate | 17 | $2,054 | $121 |
| Oxybutynin Chloride Er | 17 | $790 | $46 |
| Nitrofurantoin Mono-Macro | 49 | $659 | $13 |
| Metronidazole | 12 | $268 | $22 |
| Ibuprofen | 23 | $206 | $9 |
| Oxycodone | 22 | $116 | $5 |
| Cephalexin | 16 | $105 | $7 |
| Sulfamethoxazole-Trimethoprim | 22 | $57 | $3 |
2019: 12 drugs
| Myrbetriq | 96 | $54,170 | $564 |
| Premarin | 82 | $31,702 | $387 |
| Estradiol | 19 | $3,541 | $186 |
| Methenamine Hippurate | 12 | $1,644 | $137 |
| Nitrofurantoin Mono-Macro | 91 | $1,185 | $13 |
| Metronidazole | 21 | $810 | $39 |
| Oxybutynin Chloride Er | 12 | $737 | $61 |
| Cephalexin | 41 | $261 | $6 |
| Betamethasone Diprop Augmented | 11 | $188 | $17 |
| Ibuprofen | 13 | $153 | $12 |
| Sulfamethoxazole-Trimethoprim | 35 | $134 | $4 |
| Fluconazole | 14 | $67 | $5 |
2018: 2 drugs
| Premarin | 18 | $6,524 | $362 |
| Nitrofurantoin Mono-Macro | 21 | $411 | $20 |
2017: 6 drugs
| Premarin | 17 | $5,507 | $324 |
| Estrace | 15 | $4,702 | $313 |
| Acetaminophen-Codeine | 22 | $311 | $14 |
| Ibuprofen | 18 | $275 | $15 |
| Lactulose | 12 | $270 | $23 |
| Sulfamethoxazole-Trimethoprim | 17 | $115 | $7 |
Money from drug and device companies
$235 in 2025
| 2025 | 3 | 6 | None | $235 |
| 2023 | 2 | 2 | $750 | $779 |
| 2022 | 3 | 3 | None | $206 |
| 2020 | 1 | 1 | None | $29 |
| 2019 | 3 | 4 | None | $414 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $110 | 2 payments
|
| Sumitomo Pharma America | Gemtesa | $95 | 3 payments
|
| Bluewind Medical | Revi | $31 | 1 payment
|
See all 6 published payments
| Sumitomo Pharma America | Meals · 2025-12-08 | Gemtesa | $31 |
| Sumitomo Pharma America | Meals · 2025-08-27 | Gemtesa | $32 |
| Abbvie | Meals · 2025-05-20 | None | $78 |
| Bluewind Medical | Meals · 2025-05-16 | Revi | $31 |
| Sumitomo Pharma America | Meals · 2025-01-29 | Gemtesa | $32 |
| Abbvie | Meals · 2025-01-08 | Botox | $32 |
See earlier years (2023, 2022, 2020, 2019)
2023: $779
| Intuitive Surgical | Da Vinci Sp | $750 | 1 payment
|
| Caldera Medical | Desara | $29 | 1 payment
|
2022: $206
| Boston Scientific | Upsylon | $108 | 1 payment
|
| Astellas Pharma US | None | $80 | 1 payment
|
| Rochester Medical | None | $18 | 1 payment
|
2020: $29
| Pfizer | Premarin | $29 | 1 payment
|
2019: $414
| Boston Scientific | Advantage Fit | $238 | 2 payments
|
| Siemens Medical Solutions USA | Magnetom Vida 3t | $157 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | None | $19 | 1 payment
|
Professional record
- NPI
- 1922397256
- Licence
- CA 135897California A135897: Current · expires 2028-12-31
- Trained
- Medical College of Wisconsin, 2011
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X); Student in a training program (390200000X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2011-04-07
- NPI last updated
- 2018-09-13
This is when the NPI record was last certified, not a medical board exam.